2 studies found for:    20850381 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
Condition: Heart Defects, Congenital
Intervention: Drug: Dexrazoxane
2 Terminated Treatment of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase (E. Coli);   Drug: asparaginase (Erwina);   Drug: dexrazoxane;   Drug: doxorubicin;   Procedure: cranial radiation (once daily fractionation);   Procedure: cranial radiation (twice-daily fractionation);   Procedure: Intrathecal chemotherapy without radiation

Indicates status has not been verified in more than two years